Rebecca Fitzgerald is a Professor of Cancer Prevention and Founding Director of the Li Ka Shing Early Cancer Institute at the University of Cambridge and practices medicine as Hon. Consultant in Gastroenterology and Cancer Medicine at Addenbrooke's Hospital. Rebecca is the Cambridge lead for the CRUK International Alliance in Early Detection (ACED). Her research aims to understand how tissues become cancerous and whether identifying pre-cancer at scale can reduce cancer morbidity and mortality, focussing on the oesophagus and stomach. Her work to develop and implement a non-endoscopic capsule sponge and related biomarker assays for detection of Barrett's oesophagus and associated dysplasia has been awarded several prizes including the Westminster Medal, an NHS Innovation prize and the Don Listwin Early Detection Prize. In 2022 Rebecca was awarded an OBE for services to cancer research. Rebecca has contributed to evidence reviews and policy work around screening including for the Department of Health in the UK and recently led a review of cancer screening for the European Commission that led to new screening policy for EU member states.

Patrick Maxwell is Regius Professor of Physic and Head of the School of Clinical Medicine at the University of Cambridge.

As a clinician scientist, he has been centrally involved in a series of discoveries that have revealed how changes in oxygenation are sensed, and how genetic alterations cause kidney disease.

Patrick is a Fellow of the Royal College of Physicians and the Academy of Medical Sciences, Director of Cambridge University Health Partners and a Non-Executive Director of Cambridge University Hospitals, Cambridge Enterprise, Scottish Mortgage Investment Trust and the International Biotechnology Turst.